Forecast of the Day: IBM
Moderna and IBM (NYSE: IBM) are collaborating to explore new technologies like artificial intelligence, blockchain and hybrid cloud to improve Covid-19 vaccine management. The aim is to identify ways technology can be used to help accelerate secure, information sharing between governments, healthcare providers, life science organizations and individuals.
Click here for full Trefis coverage of IBM
- Up 14% This Year, Will IBM’s Gains Continue Following Q1 Results?
- Up 17% This Year, Why Is IBM Stock Outperforming?
- Up 21% In The Last Six Months, Will IBM Stock See Further Gains Post Q4?
- IBM Stock Gains 10% Over The Last Month On Strong Earnings, AI Progress. What’s Next?
- With Stock Down 1% YTD, Will Lackluster IT Spending Impact IBM’s Q3 Results?
- How Will IBM Stock Trend Post Q2 Earnings?
While IBM stock may have moved, 2020 has created many pricing discontinuities which can offer attractive trading opportunities. For example, you’ll be surprised how the stock valuation for Oracle vs. Humana shows a disconnect with their relative operational growth. You can find many such discontinuous pairs here.
See all Trefis Price Estimates and Download Trefis Data here
What’s behind Trefis? See How It’s Powering New Collaboration and What-Ifs For CFOs and Finance Teams | Product, R&D, and Marketing Teams